Kingsview Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$312K Buy
1,011
+144
+17% +$44.7K ﹤0.01% 1163
2026
Q2
$243K Buy
867
+38
+5% +$10K ﹤0.01% 1282
2026
Q1
$221K Buy
+829
New +$224K ﹤0.01% 1210
2025
Q4
– Sell
-747
Closed -$214K – 1295
2025
Q3
$214K Buy
+747
New +$200K ﹤0.01% 1112

Other funds holding LH

Kingsview Wealth Management's LH Position: Q3 2026 in Review

Kingsview Wealth Management increased its Labcorp (LH) stake by 17% in Q3 2026, buying an estimated $44.7K and bringing the position to 1,011 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.

Kingsview Wealth Management first reported a position in LH in Q3 2025 and has held it in 4 quarters since. 1,083 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Kingsview Wealth Management held 1,011 shares of Labcorp worth $312K as of Q3 2026.
  • Kingsview Wealth Management bought 144 Labcorp shares in Q3 2026, an estimated $44.7K.
  • Labcorp made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q3 2026, its #1163 holding.
  • Kingsview Wealth Management first reported a position in Labcorp in Q3 2025 and has held it in 4 quarters since.
  • 1,083 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Kingsview Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.